DUBAI: Kuwait and Bahrain have approved the use of Sotrofimab as a treatment for the coronavirus.
The GSK and Vir Biotechnology created drug can be used for the treatment of mild to moderate cases of COVID-19, state agencies KUNA and Bahrain News Agency reported.
The UAE also approved the drug’s use earlier in the week.
Research has shown the use of the drug leads to a reduction in the number of cases requiring hospitalization for more than 24 hours and a reduction in the number fatalities by 85 percent, when administered at an early stage of treatment.
Meanwhile Kuwait has also announced on Wednesday a $40 million donation to COVAX, the international program designed to help supply developing countries with vaccines against the disease, KUNA said.
